GUEST EDITORIAL - P53 TESTING IN COLORECTAL CANCER
SURVEILLANCE IN PATIENTS WITH ULCERATIVE COLITIS Can screening for p53
mutations help identify UC patients at increased risk for colorectal cancer?
Bret A. Lashner, MD of the Cleveland Clinic Foundation discusses this issue
and comments on its potential impact on clinical decision making. Medscape
Gastroenterology, 1999 http://www.medscape.com/13514.rhtml <a